Dec 04, 2018
CARsgen Presents Preliminary Results of CAR-BCMA T Cell Therapy at ASH 2018
Dec 03, 2018
CAR T-Cell Therapies Show Durable Responses, New Research Also Explores Combination Therapies to Extend and Enhance Treatment Responses
Dec 03, 2018
WUGEN Presents Updated Preclinical Data on Novel Allogeneic CAR-T Platform at ASH Annual Meeting
Dec 03, 2018
Arix Bioscience plc: Autolus Presents Initial AUTO3 Clinical Data at ASH
Dec 02, 2018
Autolus Therapeutics Presents Initial AUTO3 Clinical Data from Phase 1/2 Clinical Trials in B cell Malignancies at the 60th ASH Annual Meeting
Dec 01, 2018
Novartis announces longer-term analyses from pivotal Kymriah® trials that showed durable responses are maintained in patients with advanced blood cancers
Nov 29, 2018
TCR2 Therapeutics wins U.S. Private Company of the Year Award at LifeStars Awards(TM) Life Sciences 2018 Event
Nov 27, 2018
The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the 60th American Society of Hematology Annual Meeting
Nov 27, 2018
Marker Therapeutics, Inc. Appoints Anthony H. Kim as Chief Financial Officer
Nov 19, 2018
Cesca Therapeutics Receives 510(k) Clearance to Market Its AXP® II AutoXpress® Platform for Clinical Cord Blood Banking
Nov 19, 2018
Actinium Pharmaceuticals, Inc. to Present at 30th Annual Piper Jaffray Healthcare Conference
Nov 13, 2018
WUGEN Announces Exclusive License Agreement for CAR-T Therapy Technologies from Washington University in St. Louis
Nov 13, 2018
F1 Oncology's International Affiliate, EXUMA Biotechnology, Announces Acquisition Of Strategic CAR-T Assets
Nov 13, 2018
Cesca Therapeutics Submits Device Master File (MAF) with the FDA for the X-LAB® Automated Cell Processing Devices
Nov 09, 2018
Methapharm Inc. announces participation in Triumvira Immunologics Inc. Convertible Debenture
Nov 05, 2018
Actinium Pharmaceuticals to Present at BIO-Europe® 24th Annual International Partnering Conference
Nov 02, 2018
Autolus Therapeutics to Present New Data at the ASH Annual Meeting
Nov 01, 2018
Autolus Therapeutics to Present New Data on Its Advanced Programmed T Cell Therapies at the 60th ASH Annual Meeting
Nov 01, 2018
WUGEN Announces Presentations at American Society of Hematology Annual Meeting
Oct 29, 2018
Novartis wins esteemed Prix Galien Foundation Best Biotechnology Product Award for CAR-T cell therapy, Kymriah®